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Abstract The Na+-H+ exchanger regulatory factor (NHE-RF)
is a cytoplasmic phosphoprotein that was first found to be
involved in protein kinase A mediated regulation of ion transport.
NHE-RF contains two distinct protein interaction PDZ
domains: NHE-RF-PDZ1 and NHE-RF-PDZ2. However, their
binding partners are currently unknown. Because PDZ domains
usually bind to specific short linear C-terminal sequences, we
have carried out affinity selection of random peptides for specific
sequences that interact with the NHE-RF PDZ domains and
found that NHE-RF-PDZ1 is capable of binding to the CFTR
C-terminus. The specific and tight association suggests a
potential regulatory role of NHE-RF in cystic fibrosis trans-
membrane conductance regulator (CFTR) function.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
The Na-H exchanger regulatory factor (NHE-RF) was
¢rst identi¢ed as a cofactor necessary for the protein kinase A
mediated inhibition of Na-H exchanger activity in renal
brush border membranes [1]. Such activity was recently con-
¢rmed in tissue culture cells using a cloned cDNA [2]. This 42
kDa phosphoprotein contains two tandem protein interaction
modules known as PDZ domains, which usually bind to short
linear C-terminal sequences [3,4]. In addition to kidney brush
border membrane where the NHE-RF protein was ¢rst iso-
lated, both the messenger RNA and the protein of NHE-RF
have been found in a wide variety of other tissues, suggesting
that its functional roles may extend to other membrane signal-
ling systems. Supporting this notion, recent studies of inter-
acting proteins for members of the ezrin-radixin-moesin
(ERM) family have identi¢ed an ERM binding phosphopro-
tein 50 (EBP50) from human placenta. Molecular cloning of
EBP50, which binds tightly to ezrin, has revealed that EBP50
is a human counterpart of NHE-RF [5]. Thus, NHE-RF is
associated with cytoskeletal structures.
Although the speci¢c mechanistic role of NHE-RF in the
PKA mediated regulation remains unknown, the phosphoryl-
ation appears to be essential for the regulatory function of
NHE-RF. Since NHE-RF contains two homologous PDZ
domains, it was thought that they might interact with the
C-termini of the Na-H exchanger and/or ezrin. Interest-
ingly, recent evidence suggests that the C-terminus of the
Na-H exchanger 3 (NHE3) is not required for the binding
of E3KARP (also known as tyrosine kinase activator-1, TKA-
1, GenBank accession number: Z50150), a homologous pro-
tein of NHE-RF with similar modulatory activity to NHE3 in
cell culture [2]. The interaction between NHE-RF (or EBP50)
and ERM protein was shown to be mediated by the N-termi-
nal domain of ezrin [5]. Thus, neither the C-terminus of
NHE3 nor that of ezrin is required for the interaction with
NHE-RF or EBP50. Therefore, the PDZ domains of NHE-
RF may interact with other additional proteins that may be
essential for the NHE-RF function in vivo.
In an e¡ort to identify binding partners of NHE-RF,
we have determined the peptide binding sequences for indi-
vidual NHE-RF PDZ domains using random peptide display
techniques [6]. We found that the two PDZ domains possess
distinct ligand speci¢city. Based on the resultant binding con-
sensus of the PDZ domains, a number of candidate inter-
acting proteins for NHE-RF have been identi¢ed. Among
them is the cystic ¢brosis transmembrane conductance regu-
lator (CFTR), whose C-terminus (TRL-COOH) matches the
binding consensus of NHE-RF-PDZ1 and binds tightly to
NHE-RF.
2. Methods and materials
2.1. Vector construction and fusion protein expression
NHE-RF cDNA was ampli¢ed from mouse total RNA by the
reverse transcriptase (RT)-PCR method and con¢rmed by DNA se-
quencing. The PCR fragments corresponding to both the full-length
coding sequence and the individual PDZ domains of NHE-RF were
subcloned into the pGEX4T2 vector in order to produce glutathione S
transferase (GST)-PDZ fusion proteins. The PCR fragments corre-
sponding to the human CFTR C-terminal regions were subcloned
into pGEX4T3 and pML80 vectors in order to produce GST-CFTR
and LacI repressor fusion of CFTR (LacI-CFTR). The PCR frag-
ments corresponding to the full-length and truncated NHE-RF were
subcloned into the pCGN vector in order to produce the 12CA5-
tagged fusion proteins in mammalian cells [7]. A series of oligonucleo-
tides were synthesized for high ¢delity PCR to amplify corresponding
coding fragments. The sequences of the oligonucleotides are available
on request. The GST fusion production and puri¢cation were carried
out according to the standard protocol provided by the manufacturer
(Pharmacia Biotech, Uppsala, Sweden). The expression of the HA-
tagged fusion proteins was carried out by transient transfection of
HEK293 cells [7].
2.2. A⁄nity panning
GST fusion proteins corresponding to NHE-RF-PDZ1 and NHE-
RF-PDZ2 were used in a⁄nity panning of the random peptide li-
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brary. The procedures for PDZ domain panning and ELISA detection
have been described previously [6].
2.3. Pull-down experiments
At 48 h post-transfection, the HEK293 cells were washed twice with
PBS and lysed in PBS supplemented with 1% Triton X-100, 5 mM
EDTA, 0.5 mM dithiothreitol, 1 mM phenylmethylsulfonyl£uoride
(PMSF), 10 mM benzamidine-HCl, 10 Wg/ml phenanthroline, 10 Wg/
ml aprotinin, 10 Wg/ml leupeptin, 10 Wg/ml pepstatin A. The super-
natant was collected after centrifugation of the lysate at 27 000Ug for
15 min at 4‡C and incubated with a GST or GST-CFTR fusion
protein bound to glutathione-agarose beads. After gentle rotation
for 1 h at 4‡C, the beads were washed once with lysis bu¡er, twice
with lysis bu¡er supplemented with 0.5 M NaCl and three times with
PBS at 4‡C. Prior to SDS-polyacrylamide gel electrophoresis (PAGE),
the bound material was eluted with SDS sample bu¡er. After SDS-
PAGE separation the NHE-RF protein was detected by immunoblot
with the mAb12CA5 antibody to the HA tag.
3. Results
3.1. Distinct binding speci¢city of the NHE-RF PDZ domains
A general feature of the PDZ domain mediated protein
interactions is their ability to recognize a short carboxylated
peptide at the C-terminus of a target protein. The crystal
structure of the third PDZ domain in PSD-95 (PSD-95
PDZ3) has revealed that the binding pocket of the PDZ do-
main recognizes the last three residues and the C-terminal
carboxyl group. Based on the cocrystal structure, amino
acid positions that are involved in determining the peptide
binding speci¢city have been inferred [8]. Comparison of pri-
mary sequences of di¡erent PDZ domains has shown a sig-
ni¢cant degree of divergence in some of the corresponding
positions, suggestive of a distinct peptide binding speci¢city
of the NHE-RF PDZ domains (Fig. 1).
To determine the peptide binding speci¢city for the PDZ
domains of NHE-RF, two GST fusion proteins corresponding
to PDZ1 (a.a. 1 to 107, NHE-RF-PDZ1) and PDZ2 (a.a. 133
to 244, NHE-RF-PDZ2) were constructed (see Section 2).
Using the puri¢ed individual fusion proteins as targets, we
carried out an a⁄nity panning selection from a library of
15-mer random peptides. This technique is based on the
strong protein-DNA interaction between the LacI repressor
and the lac operator sequence [9] and has previously been
used to decode the binding speci¢city of various PDZ do-
mains including an orphan PDZ domain of neuronal nitric
oxide synthase (nNOS) [6] and PDZ domains of Inactiva-
tion-no-afterpotential D (INAD) ([10] and also see Section
2). After three rounds of a⁄nity panning, the binding specif-
icity of the isolated clones was examined by ELISA. The
clones that speci¢cally interacted with the NHE-RF PDZ do-
mains, but not with the control GST fusion protein, were
selected for DNA sequencing, which allows for the deduction
of amino acid sequence of the binding peptides.
Fig. 2A shows an amino acid sequence alignment of the 34
independent peptide sequences recognized by NHE-RF-
PDZ1. Among them, 20 clones end with TRL, ¢ve end with
TRF, ¢ve end with SRL, two end with TYL, one ends with
TRI, and one ends with ARL. There is no strong amino acid
preference at the 33 position. The shortest peptide is the
RFBP-I7 clone, where TRL alone is su⁄cient for binding to
NHE-RF-PDZ1. Based on the amino acid abundance at the
last three positions, the consensus sequence for NHE-RF-
PDZ1 is S/T- R/Y-L-COOH (Fig. 3A). In the 16 independent
peptide sequences recognized by NHE-RF-PDZ2, leucine
again is strongly preferred (81%) at the 0 position. At the
31 position, tryptophan is also strongly preferred (93%). In-
terestingly, the 33 position of the NHE-RF-PDZ2 binding
peptides is strongly preferred by serine or threonine (81%).
Based on the amino acid abundance at each position, the
consensus sequence for NHE-RF-PDZ2 is S-S/T-W-L-
COOH (Fig. 3B). Consistent with the binding preference, we
failed to detect any of the identi¢ed peptides capable of bind-
ing to both NHE-RF PDZ domains (Wang and Li, unpub-
lished data). Thus, the NHE-RF-PDZ1 and NHE-RF-PDZ2
exhibit distinct peptide binding speci¢city.
3.2. Biochemical association between CFTR and NHE-RF
Identi¢cation of the ligand binding consensus of PDZ do-
mains 1 and 2 of NHE-RF allows for a search of potential
NHE-RF interacting proteins present in protein sequence da-
tabases. Interestingly, the human CFTR protein C-terminus
ends with TRL-COOH, a perfect match for the PDZ1 binding
consensus. This region is highly conserved and found in
CFTR proteins from various species (Fig. 4), consistent with
the idea that it may serve an important physiological function.
To test the possible interaction between CFTR and NHE-RF,
we generated three LacI fusion proteins corresponding to the
C-terminus of human CFTR (Fig. 5A). The CFTR-C1 con-
tains the whole putative C-terminal cytoplasmic region of
CFTR (a.a. 1211 to 1481) including the predicted nucleotide
binding domain 2 (NBD2). The CFTR-C2 contains the last 94
amino acids immediately downstream from the NBD2. The
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Fig. 1. Amino acid sequence alignment of the PDZ domains of NHE-RF and TKA-1 (Z50150) against the sequence of PDZ3 of PSD-95.
Highlighted residues are conserved among most of the aligned PDZ domains. The black bars above the PSD-95 sequence indicate regions or
residues that are putatively involved in determining the binding speci¢city of peptides [8]. The boxed residue is thought to determine the side
chain preference at the 32 position of the bound peptide [6,8]. The numbers indicate the amino acid positions in the corresponding proteins.
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CFTR-C3 contains only the last 15 amino acids. The three
fusion proteins produced in Escherichia coli were incubated
with puri¢ed NHE-RF-PDZ1 and NHE-RF-PDZ2. All three
CFTR-LacI fusion proteins are capable of binding to NHE-
RF-PDZ1 but not to NHE-RF-PDZ2 as determined by ELI-
SA. The binding signal of the CFTR C-terminal fusions to
NHE-RF is comparable with that of a peptide (RFBP-I31)
that is isolated from the previous a⁄nity panning experiment
(Fig. 5B).
To assess the binding a⁄nity between NHE-RF and CFTR,
we performed surface plasmon resonance (SPR) measure-
ments (BIACore) using the immobilized CFTR peptide. By
perfusing various concentrations of the puri¢ed NHE-RF-
PDZ1, we found that the dissociation constant of NHE-RF-
PDZ1 with the CFTR C-terminal peptide is 48 nM.
The C-terminal region of NHE-RF contains several phos-
phorylation sites including a putative kinase A site (Ser-338)
and two potential cdc2 sites (Ser-279 and Ser-301). Because it
was thought that phosphorylation may play a key role in the
NHE-RF function, we tested whether the presence of the C-
terminal region of NHE-RF would a¡ect the interaction be-
tween NHE-RF-PDZ1 and the C-terminus of CFTR. The
full-length NHE-RF as well as the truncated NHE-RF (with
the deletion of the C-terminal region which contains the phos-
phorylation sites) were transfected in HEK293 cells. At 48 h
after transfection, cells were harvested and lysed in the pres-
ence of 1% Triton X-100 (see Section 2). The expression of
NHE-RF can be detected by immunoblot analysis. The full-
length NHE-RF from transfected cells are two closely migrat-
ing bands (Fig. 6, lane 4), characteristic of the NHE-RF pro-
tein in native tissues (Wang and Li, unpublished data). The
lysates were incubated with either GST alone or the GST-
CFTR-C3 fusion protein. Fig. 6 shows that GST-CFTR-C3,
containing only the last 15 amino acids of CFTR, is capable
of pulling down both the truncated NHE-RF, containing only
the two PDZ domains, and the full-length NHE-RF from
HEK293 cells (Fig. 6, lanes 3 and 6).
4. Discussion
A⁄nity selection of speci¢c binding sequences from a ran-
dom peptide library has revealed that PDZ1 and PDZ2 of
NHE-RF have distinct ligand binding speci¢city. Interest-
ingly, the binding consensus of NHE-RF-PDZ1 is in good
agreement with the C-terminal sequence of CFTR. The results
of binding studies demonstrate that NHE-RF is capable of
interacting directly with CFTR.
Mutagenesis and structural studies have shown that histid-
ine-372 of PSD-95 is essential for determining the amino acid
speci¢city at the 32 position of the T/S-X-V binding consen-
sus [6,8]. The strong preference of serine or threonine at the
32 position for NHE-RF-PDZ1 and NHE-RF-PDZ2 is in
good agreement with the existing evidence, since histidine res-
idues are found in both PDZ domains at the corresponding
positions (see boxed residue in Fig. 1). The PSD-95 PDZ3
binds to a consensus of E-(S/T)-X-V-COOH [6]. Consistent
with the weak binding preference at the 31 position, a co-
crystal of PSD-95 PDZ3 with a bound peptide shows that the
side chain of the 31 residue points away from the PDZ bind-
ing pocket [8]. In contrast to a typical PDZ domain, such as
PDZ3 of PSD-95, both NHE-RF-PDZ1 and NHE-RF-PDZ2
have strong preference for residues at the 31 position (Fig. 3),
supporting the notion that NHE-RF-PDZ1 and NHE-RF-
PDZ2 have distinct substrate speci¢city.
Although it is well documented that NHE-RF serves as a
cofactor in the cAMP mediated inhibition of NHE3 [1,11], it
remains unknown whether NHE-RF participates in the PKA
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Fig. 2. Amino acid sequence alignment of the binding peptides of
the NHE-RF PDZ domains. A group of 48 colonies was randomly
selected after three rounds of a⁄nity panning against either NHE-
RF-PDZ1 or NHE-RF-PDZ2 and their binding speci¢city was
tested individually by the LacI ELISA [6]. The NHE-RF-PDZ-spe-
ci¢c clones were sequenced. Amino acid sequences of independent
clones are aligned. The asterisk indicates a stop codon. The three
italic ‘GGG’s are part of the linker sequence which separates LacI
from random peptides in the vector.
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modulation through a more general mechanism which is not
restricted to Na-H exchangers. It is clear, however, that the
NHE-RF protein has been found in many tissues including,
but not limited to, tissues where NHE3 is expressed [1,5].
Most importantly, in addition to renal brush border mem-
brane, we found that the NHE-RF protein was also present
in lung and pancreas, which are the sites where the function of
CFTR is essential ([12] and Wang and Li, unpublished re-
sults). It is, therefore, conceivable that NHE-RF may play
an important regulatory role in membrane signalling systems
in addition to Na-H exchangers.
Besides activation by protein kinase A, the CFTR chloride
channel activity is also regulated by a number of other mech-
anisms. In particular, it is known that actin ¢laments are
somehow involved in channel gating of CFTR [13^15]. For
example, cytochalasin D signi¢cantly attenuates both 36Cl3
e¥uxes and whole-cell current in bronchial epithelial cells
after activation by typical CFTR agonists. What would be
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Fig. 3. Amino acid abundance at each position for the NHE-RF-PDZ1 (panel A) and NHE-RF-PDZ2 (panel B) binding peptides was deter-
mined and is shown in histogram format. The horizontal axis indicates the amino acid in single-letter codes. The ¢lled bars show actual abun-
dance in percentage; empty bars indicate expected abundance in the starting library.
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the functional role of the NHE-RF and CFTR interaction?
The ability of NHE-RF to bind both CFTR and ezrin sug-
gests a working model whereby NHE-RF serves as an anchor
linking CFTR to ezrin. Because ezrin normally binds to actin,
the linkage mediated by NHE-RF would allow for a physical
connection of membrane-bound CFTR to cytoskeletal com-
ponents.
The PKA mediated activation is essential for CFTR func-
tion in vivo [16]. However, the mechanistic details of the PKA
stimulation remain unknown. In addition to direct phospho-
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Fig. 4. Amino acid sequence alignment of C-termini of CFTR from human (P13569), rat, mouse (M60439), rabbit (Q00554), bovine (P35071),
sheep (U20418), dog¢sh (P26362), and Xenopus (U60209). The bracketed last three residues are in good agreement with the binding consensus
of NHE-RF-PDZ1.
Fig. 5. Direct binding of the CFTR C-terminus to NHE-RF-PDZ1.
A: Schematic diagram of three LacI fusion constructs of CFTR C-
terminal fragments. The shaded boxes represent the LacI portion;
the ¢lled boxes represent the CFTR coding segment. The numbers
above each construct indicate the corresponding amino acid posi-
tions in the human CFTR protein. B: Binding of CFTR to the
NHE-RF PDZ domains. The association of LacI fusions with vari-
ous target proteins was tested by ELISA. Microtiter wells were
coated with BSA only (dashed box), GST-NAB (a control GST fu-
sion protein, open box), GST-NHE-RF-PDZ1 (¢lled box), or GST-
NHE-RF-PDZ2 (gray box). Binding signal is shown in optical den-
sity at a wavelength of 405 nm, and individual LacI fusions are as
indicated. The corresponding amino acid sequence of RFBP-I31 can
be found in Fig. 2A.
Fig. 6. Binding of CFTR to NHE-RF. Full-length and truncated
NHE-RF were expressed transiently in HEK293 cells as 12CA5-
tagged fusions. At 48 h after transfection, soluble cell lysates were
prepared (lanes 1 and 4). After incubation with GST only (lanes 2
and 5) or GST-CFTR-C3 (lanes 3 and 6), the bound proteins were
separated by SDS-PAGE. The full-length or truncated NHE-RF
were detected by probing the ¢lter with the monoclonal antibody
speci¢c for the 12CA5 tag. The protein molecular weight standards
are marked on the left in kDa.
S. Wang et al./FEBS Letters 427 (1998) 103^108 107
rylation of the CFTR protein, existing evidence also supports
a model of the PKA-stimulated vesicle fusion [17]. Recent
work reported that ezrin, a member of the ERM family, is
capable of binding to PKA regulatory subunit II (RII) [18].
Thus, NHE-RF may also function by binding to members of
the ERM family, thereby recruiting PKA machinery into the
proximity of the acting site.
Cystic ¢brosis is a common genetic disorder in the Cauca-
sian population. Although the major mutation of vF508 ac-
counts for 70% of the disease alleles, more than 550 additional
mutant alleles of di¡erent forms have been identi¢ed. Inter-
estingly, there are at least three nonsense mutations mapped
at the C-terminus after NBD2 (see a recent review by Zielen-
ski and Tsui [12]). These genetic data link the CFTR function
to the integrity of the C-terminus, which may function by
interacting with cytoplasmic proteins, such as NHE-RF.
With the identi¢cation of the peptide binding preference of
the NHE-RF PDZ domains and biochemical con¢rmation of
the physical association between NHE-RF and CFTR in vi-
tro, it is now possible to design experiments to test directly
whether and how NHE-RF may participate in CFTR func-
tion in vivo.
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